1. |
Cordier JF,Chailleux E,Lauque D,et al.Primary pulmonary lymphomas.A clinical study of 70 cases in nonimmunocompromised patients.Chest,1993,103:201-208.
|
2. |
Freeman C,Berg JW,Cutler SJ.Occurrence and prognosis of extranodal lymphomas.Cancer,1972,29:252-260.
|
3. |
Zinzani PL,Martelli M,Poletti V,et al.Practice guidelines for the management of extranodal non-Hodgkin’s lymphomas of adult non-immunodeficient patients.Part I: primary lung and mediastinal lymphomas.A project of the Italian Society of Hematology,the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.Haematologica,2008,93:1364-1371.
|
4. |
Nicholson AG,Wotherspoon AC,Diss TC,et al.Reactive pulmonary lymphoid disorders.Histopathology,1995,26:405-412.
|
5. |
Chow WH,Ducheine Y,Hilfer J,et al.Chronic pneumonia.Primary malignant non-Hodgkin’s lymphoma of the lung arising in mucosa-associated lymphoid tissue.Chest,1996,110:838-840.
|
6. |
Bertoni F,Zucca E.Delving deeper into MALT lymphoma biology.J Clin Invest,2006,116:22-26.
|
7. |
趙倩,趙紹宏,蔡祖龍,等.原發性肺淋巴瘤的CT表現.中國醫學影像學雜志,2009,17:42-45.
|
8. |
Zompi S,Couderc LJ,Cadranel J,et al.Clonality analysis of alveolar B lymphocytes contributes to the diagnostic strategy in clinical suspicion of pulmonary lymphoma.Blood,2004,103:3208-3215.
|
9. |
Troch M,Streubel B,Petkov V,et al.Does MALT lymphoma of the lung require immediate treatment? An analysis of 11 untreated cases with long-term follow-up.Anticancer Res,2007,27:3633-3637.
|
10. |
Conconi A,Martinelli G,Thiéblemont C,et al.Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type.Blood,2003,102:2741-2745.
|
11. |
Raderer M,Jäger G,Brugger S,et al.Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma.Oncology,2003,65:306-310.
|